Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

State Estimates of Major Depressive Episode among Adolescents: 2013 and 2014.

Lipari RN, Hughes A, Williams M.

The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-.

2.

Comparison of NSDUH Mental Health Data and Methods with Other Data Sources.

Hedden S, Gfroerer J, Barker P, Smith S, Pemberton MR, Saavedra LM, Forman-Hoffman VL, Ringeisen H, Novak SP.

CBHSQ Data Review. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2012-.

3.

Serious Mental Health Challenges among Older Adolescents and Young Adults.

Lipari RN, Hedden SL.

The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-.

4.

Substance Use and Mental Health Estimates from the 2013 National Survey on Drug Use and Health: Overview of Findings.

Lipari RN, Hedden SL, Hughes A.

The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-.

5.

Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries.

Gelaye B, Rondon MB, Araya R, Williams MA.

Lancet Psychiatry. 2016 Oct;3(10):973-982. doi: 10.1016/S2215-0366(16)30284-X. Review.

6.
7.

Staging Models in Bipolar Disorder: A Systematic Review of the Literature.

Muneer A.

Clin Psychopharmacol Neurosci. 2016 May 31;14(2):117-30. doi: 10.9758/cpn.2016.14.2.117. Review.

8.

Depression in dementia.

Kitching D.

Aust Prescr. 2015 Dec;38(6):209-2011. Review.

9.

Stress-Related Immune Markers in Depression: Implications for Treatment.

Hughes MM, Connor TJ, Harkin A.

Int J Neuropsychopharmacol. 2016 Jan 16. pii: pyw001. doi: 10.1093/ijnp/pyw001. [Epub ahead of print] Review.

10.

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.

Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

BMJ. 2015 Dec 8;351:h6019. doi: 10.1136/bmj.h6019. Review.

11.

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.

Prabhavalkar KS, Poovanpallil NB, Bhatt LK.

Front Pharmacol. 2015 Oct 23;6:242. doi: 10.3389/fphar.2015.00242. Review.

12.

A meta-analysis of lipid peroxidation markers in major depression.

Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL.

Neuropsychiatr Dis Treat. 2015 Sep 29;11:2479-91. doi: 10.2147/NDT.S89922. Review.

13.

Impact of untreated major depressive disorder on cognition and daily function.

Culpepper L.

J Clin Psychiatry. 2015 Jul;76(7):e901. doi: 10.4088/JCP.13086tx4c. Review.

15.

Common Questions About the Pharmacologic Management of Depression in Adults.

Kovich H, DeJong A.

Am Fam Physician. 2015 Jul 15;92(2):94-100. Review.

16.

[Cognitive dysfunctions in depression - underestimated symptom or new dimension?].

Jarema M, Dudek D, Czernikiewicz A.

Psychiatr Pol. 2014 Nov-Dec;48(6):1105-16. doi: 10.12740/PP/31215. Review. Polish.

17.

Maintenance Deep Transcranial Magnetic Stimulation Sessions are Associated with Reduced Depressive Relapses in Patients with Unipolar or Bipolar Depression.

Rapinesi C, Bersani FS, Kotzalidis GD, Imperatori C, Del Casale A, Di Pietro S, Ferri VR, Serata D, Raccah RN, Zangen A, Angeletti G, Girardi P.

Front Neurol. 2015 Feb 9;6:16. doi: 10.3389/fneur.2015.00016. Review.

18.

Differential diagnosis of bipolar disorder and major depressive disorder.

Hirschfeld RM.

J Affect Disord. 2014 Dec;169 Suppl 1:S12-6. doi: 10.1016/S0165-0327(14)70004-7. Review.

19.

Bipolar disorders in the new DSM-5 and ICD-11 classifications.

de Dios C, Goikolea JM, Colom F, Moreno C, Vieta E.

Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):179-85. Review. English, Spanish.

20.
Items per page

Supplemental Content

Loading ...
Support Center